Literature DB >> 31785756

Unplanned Admissions Following Hip Arthroscopy: Incidence and Risk Factors.

Jerry Y Du1, Derrick M Knapik1, Nikunj N Trivedi1, Lakshmanan Sivasundaram1, Richard C Mather2, Shane J Nho3, Michael J Salata4.   

Abstract

PURPOSE: To determine the rate of and risk factors for 30-day unplanned admissions following hip arthroscopy in a U.S.
METHODS: Patients undergoing hip arthroscopy were identified in the American College of Surgeons National Surgical Quality Improvement Program database using validated Current Procedural Terminology and International Classification of Diseases, Ninth Revision and Tenth Revision codes. Patient demographics, comorbidities, preoperative laboratory values, surgical details, and postoperative outcomes were compared between patients with unplanned admissions and those without. Univariate analysis comparing study cohorts was performed using 2-tailed Student t tests with Levene's test for equality of variance or χ2/Fisher exact tests as appropriate. Using variables that were significant in the univariate analysis, we created Cox proportional hazard models to identify independent predictors for unplanned admission.
RESULTS: A total of 1931 cases of hip arthroscopy were identified. There were 18 cases of unplanned admissions within 30 days of index procedure (0.9%). The median time to unplanned admission was 14.5 days (interquartile range: 3.875-25.125 days). The most common reasons for admission were surgical-site infection (11.1%), wound complications (11.1%), and thromboembolic events (11.1%). There were 4 patients who required reoperation (22.2%). There were 7 cases (39.0%) that were readmitted for reasons unrelated to the index hip arthroscopy procedure. Multivariate analysis identified increasing body mass index, chronic corticosteroid use, and perioperative blood transfusion as factors independently associated with increased risk for unplanned admission.
CONCLUSIONS: There exists a low incidence of 30-day unplanned admission, predominantly secondary to surgical-site infections, wound complications, and thromboembolic events. Independent risk factors for unplanned admission include greater body mass index, chronic corticosteroid use, and perioperative transfusions. LEVEL OF EVIDENCE: Level III Retrospective Cohort Study.
Copyright © 2019 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31785756     DOI: 10.1016/j.arthro.2019.06.021

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  5 in total

1.  Rates of readmission and reoperation following pelvic osteotomy in adolescent patients: a database study evaluating the pediatric health information system.

Authors:  Millis Faust; Sachin Allahabadi; Ishaan Swarup
Journal:  J Hip Preserv Surg       Date:  2022-01-21

2.  Increased Readmission Rates but No Difference in Complication Rates in Patients Undergoing Inpatient Versus Outpatient Hip Arthroscopy: A Large Matched-Cohort Insurance Database Analysis.

Authors:  Elyse J Berlinberg; Enrico M Forlenza; Harsh H Patel; Ruby Ross; Randy Mascarenhas; Jorge Chahla; Shane J Nho; Brian Forsythe
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-05-28

3.  Machine Learning Model Identifies Increased Operative Time and Greater BMI as Predictors for Overnight Admission After Outpatient Hip Arthroscopy.

Authors:  Bryant M Song; Yining Lu; Ryan R Wilbur; Ophelie Lavoie-Gagne; Ayoosh Pareek; Brian Forsythe; Aaron J Krych
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-11-12

4.  Effect of Perioperative Opioid Use on Patients Undergoing Hip Arthroscopy.

Authors:  Miranda J Rogers; Mark W LaBelle; Jaewhan Kim; Temitope F Adeyemi; Christopher E Sciarretta; Christina E Bokat; Travis G Maak
Journal:  Orthop J Sports Med       Date:  2022-03-07

Review 5.  Post-operative septic arthritis after arthroscopy: modern diagnostic and therapeutic concepts.

Authors:  Andreas Voss; Christian G Pfeifer; Maximilian Kerschbaum; Markus Rupp; Peter Angele; Volker Alt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-03-23       Impact factor: 4.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.